Summary of Study ST000138

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000123. The data can be accessed directly via it's Project DOI: 10.21228/M8PC7J This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST000138
Study TitleTargeted LC MS of acylcarnitines: TLCMS
Study SummaryAcylcarnitines (panel of 66 quantitated acylcarnitines) analyzed by LC/MS/MS using flow injection analysis with electrospray ionization
Institute
University of Florida
DepartmentPharmacotherapy and Translational Research
Last NameCooper-DeHoff
First NameRhonda
Emaildehoff@cop.ufl.edu
Submit Date2015-01-08
Raw Data AvailableYes
Raw Data File Type(s)d
Uploaded File Size1.3 G
Analysis Type DetailLC-MS
Release Date2016-06-18
Release Version1
Rhonda Cooper-DeHoff Rhonda Cooper-DeHoff
https://dx.doi.org/10.21228/M8PC7J
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:

Subject:

Subject ID:SU000157
Subject Type:Human
Subject Species:Homo sapiens
Taxonomy ID:9606
Human Inclusion Criteria:Participants with a baseline fasting glucose < 100 mg/dl and a fasting glucose ? 100 mg/dl at the end of atenolol treatment are considered to have developed IFG. Participants with a baseline fasting glucose < 100 mg/dl and a fasting glucose that remained < 100 mg/dl at the end of atenolol treatment are considered to have not developed IFG.
Human Exclusion Criteria:Participants with a fasting glucose ? 100 mg/dl at baseline are excluded from this study.
Species Group:Human
  logo